AR027287A1 - Gonadotrofina - Google Patents
GonadotrofinaInfo
- Publication number
- AR027287A1 AR027287A1 ARP010100325A ARP010100325A AR027287A1 AR 027287 A1 AR027287 A1 AR 027287A1 AR P010100325 A ARP010100325 A AR P010100325A AR P010100325 A ARP010100325 A AR P010100325A AR 027287 A1 AR027287 A1 AR 027287A1
- Authority
- AR
- Argentina
- Prior art keywords
- dose
- given
- days
- medication
- range
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Uso de la hormona de estimulacion folicular y/o un análogo biologicamente activo de la misma para producir una medicacion para tratar la infertilidad delas mujeres. La medicacion se suministrará en una dosis inicial que oscilará entre 100 y hasta 600 IU, seguida por una segunda dosis suministrada al menos 3días después de la fase de estimulacion. En una inclusion, la dosis se suministrará en una dosis que oscilará entre 300 y hasta 600 IU y la misma sesuministrará todos los terceros días durante los primeros 6 días de la fase de estimulacion. En otra inclusion, la dosis inicial oscila entre 100 y hasta 500IU, y la segunda dosis se suministra entre los tres y seis, preferentemente cuatro, días después de la dosis inicial.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00300591 | 2000-01-27 | ||
EP00302840A EP1142582A1 (en) | 2000-04-04 | 2000-04-04 | Use of FSH for treating infertility |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027287A1 true AR027287A1 (es) | 2003-03-19 |
Family
ID=26072975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100325A AR027287A1 (es) | 2000-01-27 | 2001-01-25 | Gonadotrofina |
Country Status (29)
Country | Link |
---|---|
US (1) | US7291593B2 (es) |
EP (2) | EP1250148B2 (es) |
JP (1) | JP5170928B2 (es) |
KR (2) | KR100871499B1 (es) |
CN (1) | CN1418107A (es) |
AR (1) | AR027287A1 (es) |
AT (1) | ATE267608T1 (es) |
AU (1) | AU783121B2 (es) |
BG (1) | BG65915B1 (es) |
BR (1) | BR0107881A (es) |
CA (1) | CA2397680A1 (es) |
CZ (1) | CZ302835B6 (es) |
DE (1) | DE60103503T3 (es) |
DK (1) | DK1250148T4 (es) |
EA (1) | EA004924B1 (es) |
EE (1) | EE05444B1 (es) |
ES (1) | ES2217113T5 (es) |
HR (1) | HRP20020630A2 (es) |
HU (1) | HU230833B1 (es) |
IL (2) | IL150837A0 (es) |
MX (1) | MXPA02007233A (es) |
NO (1) | NO324626B1 (es) |
PL (1) | PL211113B1 (es) |
PT (1) | PT1250148E (es) |
RS (1) | RS50805B (es) |
SI (1) | SI1250148T2 (es) |
SK (1) | SK287717B6 (es) |
TR (1) | TR200401810T4 (es) |
WO (1) | WO2001054715A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA009330B1 (ru) * | 2001-09-12 | 2007-12-28 | Апплайд Резеч Системз Арс Холдинг Н.В. | Способ содействия имплантации и/или снижения частоты выкидышей и набор для его осуществления |
YU21104A (sh) | 2001-09-12 | 2006-08-17 | Applied Research Systems Ars Holding N.V. | Upotreba hcg i lh u kontrolisanoj hiperstimulaciji ovarijuma |
AU2002324183B2 (en) * | 2001-09-12 | 2007-10-25 | Merck Serono Sa | Use of hCG and LH in controlled ovarian hyperstimulation |
UA88879C2 (en) * | 2003-09-02 | 2009-12-10 | Эплайд Рисерч Системз Эрс Холдинг Н.В. | Fsh glycosylation mutant |
US7481748B2 (en) * | 2005-09-22 | 2009-01-27 | Kurt Manufacturing Company, Inc. | Locking mechanism for a bicycle trainer |
EP2150271A1 (en) * | 2007-05-11 | 2010-02-10 | The Texas A & M Univsersity System | Hormone normalization therapy and uses thereof |
AR081755A1 (es) | 2010-04-02 | 2012-10-17 | Hanmi Holdings Co Ltd | Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo |
WO2015089656A1 (en) * | 2013-12-20 | 2015-06-25 | Fertilify Inc. | Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health |
ES2904787T3 (es) * | 2017-09-01 | 2022-04-06 | Ferring Bv | Composición para la estimulación ovárica controlada |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725579A (en) * | 1985-02-21 | 1988-02-16 | Serono Laboratories, Inc. | Method of in vitro fertilization by a unique combination of gonadotropins |
-
2001
- 2001-01-09 PT PT01900491T patent/PT1250148E/pt unknown
- 2001-01-09 TR TR2004/01810T patent/TR200401810T4/xx unknown
- 2001-01-09 RS YUP-567/02A patent/RS50805B/sr unknown
- 2001-01-09 MX MXPA02007233A patent/MXPA02007233A/es active IP Right Grant
- 2001-01-09 KR KR1020077017998A patent/KR100871499B1/ko active IP Right Grant
- 2001-01-09 AU AU25321/01A patent/AU783121B2/en not_active Expired
- 2001-01-09 JP JP2001554698A patent/JP5170928B2/ja not_active Expired - Lifetime
- 2001-01-09 KR KR1020027009518A patent/KR100871502B1/ko active IP Right Grant
- 2001-01-09 US US10/182,138 patent/US7291593B2/en not_active Expired - Lifetime
- 2001-01-09 EE EEP200200415A patent/EE05444B1/xx unknown
- 2001-01-09 WO PCT/GB2001/000065 patent/WO2001054715A1/en active IP Right Grant
- 2001-01-09 BR BR0107881-0A patent/BR0107881A/pt not_active Application Discontinuation
- 2001-01-09 PL PL356925A patent/PL211113B1/pl unknown
- 2001-01-09 EA EA200200801A patent/EA004924B1/ru not_active IP Right Cessation
- 2001-01-09 ES ES01900491T patent/ES2217113T5/es not_active Expired - Lifetime
- 2001-01-09 SK SK1096-2002A patent/SK287717B6/sk not_active IP Right Cessation
- 2001-01-09 AT AT01900491T patent/ATE267608T1/de active
- 2001-01-09 DE DE60103503T patent/DE60103503T3/de not_active Expired - Lifetime
- 2001-01-09 EP EP01900491A patent/EP1250148B2/en not_active Expired - Lifetime
- 2001-01-09 SI SI200130111T patent/SI1250148T2/sl unknown
- 2001-01-09 CN CN01806573A patent/CN1418107A/zh active Pending
- 2001-01-09 IL IL15083701A patent/IL150837A0/xx unknown
- 2001-01-09 CA CA002397680A patent/CA2397680A1/en not_active Abandoned
- 2001-01-09 EP EP04006375A patent/EP1442748A1/en not_active Withdrawn
- 2001-01-09 CZ CZ20022555A patent/CZ302835B6/cs not_active IP Right Cessation
- 2001-01-09 DK DK01900491T patent/DK1250148T4/da active
- 2001-01-09 HU HU0204324A patent/HU230833B1/hu unknown
- 2001-01-25 AR ARP010100325A patent/AR027287A1/es unknown
-
2002
- 2002-07-11 NO NO20023354A patent/NO324626B1/no not_active IP Right Cessation
- 2002-07-22 IL IL150837A patent/IL150837A/en active IP Right Grant
- 2002-07-23 BG BG106943A patent/BG65915B1/bg unknown
- 2002-07-25 HR HRP20020630 patent/HRP20020630A2/hr not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2167061T3 (es) | Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino. | |
ES2162517T3 (es) | Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia. | |
BR0108584A (pt) | Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva | |
ES2125380T3 (es) | Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos. | |
AR037592A1 (es) | Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno | |
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
MX169322B (es) | Formulacion farmaceutica de liberacion prolongada | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
ES2117015T3 (es) | Composiciones que contienen sumatriptan. | |
AR040722A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
ES2183841T3 (es) | Formas de dosificacion para administrar un farmasco en una formulacion lquidid. | |
ATE333896T1 (de) | Vaskularisierungsinhibitoren | |
DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
ES2091001T3 (es) | Capsula que contiene un componente susceptible de degradacion y un polimero compuesto. | |
DE60019334D1 (de) | Antivirale arznei | |
IT1255460B (it) | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive | |
AR027287A1 (es) | Gonadotrofina | |
DK1112060T3 (da) | Doseringsform anvendende flydende formulering | |
JO2506B1 (en) | Dosage titration device in hydrofluoroalkan propellants | |
ES2154021T3 (es) | Preparados estimulantes del crecimiento de las uñas. | |
AR015966A1 (es) | Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito | |
DE60102590T2 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
FR2765483B1 (fr) | Medicament destine a traiter les dysfonctions erectiles | |
AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
CO5200833A1 (es) | Regimenes de dosificacion para lasofoxifeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |